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Relationship of Self-reported Attentional Fatigue to Perceived Work Ability in 
      Breast Cancer Survivors 
Diane Von Ah; Susan Storey; Adele Crouch; Shelley A. Johns; Jill Dodson; Sarah Dutkevitch 
Breast cancer survivors (BCS) have identified attentional fatigue as a frequent and 
troublesome symptom during and following treatment.1 -4   The ability to pay attention is 
necessary to complete  tasks and activities, and problem solve. Attention requires ongoing  
mental effort. For BCS,  the prolonged or intense use of attention to address the competing 
mental demands associated with illness, treatment and daily life activties, can lead to attentional 
fatigue and result in decreased effectiveness in activity.5 
 Attentional fatigue, a domain of cognitive function, is often used interchangeably with 
the terms cognitive dysfunction,cognitive  impairment, cognitive fatigue or tiredness. Seminal 
research, however, delineates attentional fatigue from these other concepts by describing 
attentional fatigue as a measurable decrease in an individual’s ability to focus and concentrate or 
to block out distractions when carrying out meaningful activities.6 Hallmark indicators of 
attentional fatigue are: increased distractibility, difficulty following a train of thought or carrying 
out usual day-to-day activities, lapses in working memory, and increased impatience or 
frustration in personal interactions.7 Although the two may coexist, physical and attentional 
fatigue differ in that an individual may not be physically tired but has a reduced ability to exert 
mental effort. 8 
Researchers have noted that BCS incur attentional fatigue more than age-matched 
controls9 and prostate cancer patients.10 Merriman and colleagues,11 found that up to 63% of 
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breast cancer patients receiving radiation therapy reported moderate to high levels of attentional 
fatigue prior to and after treatment, suggesting that this is a prevalent and persistent problem for 
BCS. In the presence of attentional fatigue, rational decision making, social interactions and 
expression of emotions may be altered subsequently impacting work ability. 
Attentional fatigue has been associated with poor outcomes in cancer survivors. One 
cross-sectional study of 134 BCS found that higher levels of attentional fatigue were related to 
more depression and physical fatigue and to lower levels of physical functioning and 
psychological well-being.8 Additional evidence suggests that BCS with greater attentional 
fatigue also experience greater mood disturbance,8 depression,12, 13 and overall poorer quality of 
life.12 However, little is known regarding the impact of attentional fatigue on work ability.  
Perceived work ability, which includes the perceived physical, psychological, and social 
resources an individual has to participate in work,14, 15 has been linked to overall well-being.16, 17 
In fact, for patients with cancer, work ability has been shown to contribute to meaning and 
purpose in life.16, 17 Work ability is dependent on the mental and physical health of the individual 
in conjunction with social skills, level of education, motivation, work demands, and the 
organizational culture.14, 17-19  Self-perceived work ability has been shown to be highly correlated 
with work performance, indicating that it is an important outcome measure.20, 21 
In a study of 74 BCS, Boykoff and colleagues (2009) noted that BCS reported deficits in 
attention, such as the tendency to daydream, and also expressed concerns about decreased 
efficiency on the job.22 Similarly, Munir and colleagues noted that BCS (N = 13) reported 
difficulty in dividing attention among tasks, which affected their confidence in work ability.23 
Although limited, these studies suggest that attentional fatigue may impact work ability in BCS. 
The challenges associated with work ability for BCS, many of whom are of working age, have 
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yet to be fully explored. Further study is needed to understand the impact of attentional fatigue 
on the work ability of BCS. While there are multiple other factors that can contribute to 
attentional fatigue, this study attempted to examine the most salient factors (age, education, 
household income and time post treatment) noted in empirical research. Therefore, the purpose 
of this study was to examine the relationship between self-reported attentional fatigue and 
perceived work ability in BCS controlling for known confounding factors including age, 
education, household income, and time post-treatment.  
The Cancer & Work Model was used to guide this study.16 This comprehensive, 
empirically derived model depicts the consequences of cancer and/or associated post-treatment 
sequelae, including symptoms such as attentional fatigue, and their ongoing influence on work-
related outcomes such as work ability.16 The Cancer & Work Model elucidates factors for  both 
the clinician and survivor to consider that may impact workability and can be addressed by the 
health care provider, survivor and the work environment.16 For this study, we are adapted the 
model to specifically examine the relationship between attentional fatigue which falls under 
symptoms and perceived work ability which is identified as an outcome in the model. See Figure 
1 for the conceptual framework. Our main interest was to advance the science by determining 
what, if any, association attentional fatigue has with perceived work ability over and above 
known confounding (demographic and medical characteristics) variables. Demographic 
characteristics of cancer survivors, including age and socio-economic status (education and 
household income), have been identified as influencing work ability.15, 16 Researchers have noted 
that younger women report more disruption from attentional fatigue,7, 10 which could negatively 
impact work ability. The level of education may also affect work ability. Higher levels of 
education have been associated with better performance on the completion of complex tasks 
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which require the ability to maintain attention.5 In addition, time post-treatment is an important 
factor influencing decisions related to work ability, with less time post-treatment associated with 
poorer work ability.15, 16, 24 Studies have mainly focused on how age and socio-economic status 
impact return to work and/or work ability. Therefore, in this study we chose to examine the 
relationships of age, education, household income, time post-treatment and attentional fatigue on 
perceived work ability in BCS. 
Methods 
A cross-sectional, descriptive design was used. A convenience sample of BCS was 
recruited from a cancer center in the Midwestern United States. Eligible women were: (1) 
between the ages of 21 and 70 years of age, (2) employed full-time or part-time outside the 
home, (3) diagnosis of stage 0-III breast cancer and (4) at least 1 year post-adjuvant treatment 
(except for anti-hormonal agents). Patients were excluded if they: (1) brain metastasis,  
(2) history of stroke, brain injury, brain surgery, or dementia (rationale being that these could 
influence the severity and impact of attentional fatigue) or (2) were unemployed during the time 
of treatment.  
Procedure 
The study was approved by the university’s institutional review board. Patients were 
screened for eligibility by clinic staff. Those expressing interest in participating in the study were 
asked to sign the informed consent and complete questionnaires eliciting demographic and 
treatment information, the Attention Function Index (AFI), and the Work Ability Index (WAI) 
and return the materials in a postage-paid envelope to the researcher. Upon receipt of these 
documents, participants were sent a $10 gift card. 
Instruments 
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Demographic and treatment characteristics were collected by the researcher. 
Demographic information included:  age, highest level of education, household income, gender, 
race, and marital status. Data regarding employment status (full-time or part-time hours) and 
type of occupation were also recorded. Participants were asked if they had changed either their 
occupation or employment status (full-time or part-time hours) after the diagnosis of breast 
cancer. Treatment characteristics included information on the date of diagnosis, location and 
stage (0-III) of the cancer, and type of treatment received (chemotherapy, surgery, radiation, 
tamoxifen, aromatase inhibitor).  
Attentional fatigue was measured using the Attention Function Index(AFI),7 which is a 
13-item (3 subscale) instrument that measures perceived effectiveness in common activities that 
require attention and working memory.7  The subscales measure effective action, attentional 
lapses and interpersonal effectiveness. 7 The AFI was developed to assess the nefarious effects of 
cognitive or mental fatigue on the activities necessary for daily functioning.7 The total AFI score 
predicts mental fatigue.7 Higher scores indicate higher levels of attention. Scores of > 75 indicate 
effective functioning, the moderate functioning range is 50-75, and a score < 50 is considered 
lower effectiveness or poor functioning.1 The AFI has established reliability and validity with a 
reported Cronbach's alpha of 0.92 for the total instrument and a range from 0.80 to 0.92 for the 3 
subscales.7 For this study, Chronbach alpha for the AFI was .96. 
Perceived work ability was measured using the Work Ability Index (WAI), which 
contains seven questions about the demands of work, the worker’s health status, and resources.25 
Response options are on a Likert-type scale from 1 to 7.  Total scores range from 7-49 points, 
and the following categories are determined by the score: poor work ability (7-27), moderate 
work ability (28-36), good work ability (37-43), and excellent work ability (44-49). Cronbach’s 
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alpha for the WAI has been reported as 0.7226 and test test reliability as 66%.27 For this study, 
Chronbach alpha for the WAI was .89. 
Data Analysis  
Data were analyzed using the Statistical Package for the Social Sciences version 23. 
Descriptive statistics were generated for demographic, disease and treatment characteristics. To 
describe the sample, thresholds for the AFI and WAI were used. However, in the final analysis, 
the overall or total score for the AFI and WAI were used as a continuous variable to increase 
power in the linear regression model. Linear regression was chosen for this cross sectional study 
to examine the relationship between self-reported attentional fatigue and perceived work ability, 
controlling for the known covariates of age, education, household income, and time post-
treatment. All of the variables were entered into the model at one time as in a prior study using 
AFI.8   An alpha level of 0.05 was used to test for statistical significance.  
 Results 
Sixty-eight female BCS, who ranged from 29 to 68 years of age (M = 52.12; SD = 8.60) 
and were on average 4.97 (SD = 3.36) years post-treatment, participated in the study. The BCS 
were primarily Caucasian, and married, had college degrees, and reported professional types of 
jobs and were employed full-time. Fifty (75%) of the participants had been diagnosed with stage 
I or II breast cancer. Most of the participants (67, 98.5%) had received surgery for treatment. 
Forty-four (65%) and forty-two (62%) of the BCS had radiation and chemotherapy respectively. 
Thirty-five (52%) of the women reported they had not taken Tamoxifen and forty-two (62%) had 
noted they had not received aromatase inhibitors.  Table 1 for the characteristics of the sample. 
The total attentional fatigue scores for the BCS in this study ranged from 34 to 129 with a 
mean score of 84.34 (SD = 24.90). Categories for the AFI scores have been previously 
7 
 
established and utilized by researchers.1,10, 11 Of the BCS in this study, 47 (69%) scored > 75 on 
the AFI, with 11 (16%) scoring in the 50-75 range and 10 (15%) having scores of < 50. Table 2 
displays the AFI scores by category. 
Perceived work ability scores for the BCS in this study ranged from 19 to 49 (M = 38.91; 
SD = 7.45).  Based on thresholds for this scale, over one-fourth (26.5%) of BCS reported 
moderate to poor perceived work ability, indicating substantial concerns regarding work 
performance. Table 2 displays the WAI scores by category. 
Linear regression results demonstrated a statistically significant relationship between 
attentional fatigue and perceived work ability (p < 0.001), explaining 40% of the variance in 
perceived work ability. Age, education, household income, and time post-treatment were not 
found to have a significant relationship with perceived work ability in this sample. See Figure 2 
for linear regression results. 
Discussion 
 
The purpose of this study was to examine the relationship between self-reported 
attentional fatigue and perceived work ability in BCS. While there are multiple other factors that 
can contribute to attentional fatigue, this study attempted to examine the most salient factors 
noted in the empirical research and appropriate to the size of the sample. To our knowledge this 
is the first study to specifically examine attentional fatigue and work ability in this context. 
Several key findings were noted in this seminal study.  
First, in this study, mean scores on the AFI were 84.34, indicating good functioning. 
However, a sub-population (15%) of BCS in our sample scored < 50 on the AFI, which indicates 
higher attentional fatigue and poorer functioning. Similarly, in a study of 73 BCS, researchers 
found that 22% of the women reported lower effectiveness and high levels of attentional fatigue 
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(AFI < 50).11 In a larger study of attentional fatigue, Cimprich and colleagues found a lower 
mean score on the AFI (M = 65.31) in 172 BCS prior to diagnostic biopsy and surgery (no 
percentages at each threshold level were reported).7 The difference in the AFI scores may be 
influenced by the timing of assessment in the illness trajectory, such as pre-treatment or during 
treatment versus post-treatment. Cimprich, Visovatti, and Ronis 7 assessed attentional fatigue 
prior to the initiation treatment of treatment for early stage breast cancer.7 The early phases in the 
trajectory of breast cancer are times of uncertainty and stress, receipt of large amounts of new 
information, and decision making, often requiring intense attention.1, 28 BCS have found reported 
that changes in cognitive function, including symptoms of attentional fatigue may persist for 
years post diagnosis and treatment2.9, 30 However, the duration, severity, and long term impact 
attentional fatigue yet to be explored among BCS. Although more research with larger sample 
sizes is needed to discern the prevalence and severity of attentional fatigue among BCS, these 
studies indicate that a substantial number of BCS incur attentional fatigue.  
Second, over one-fourth of the 68 BCS in our study experienced moderate to poor work 
ability. These findings are significant since up to 90% of BCS return to work.31, 32 Furthermore; 
work ability has been noted by BCS to contribute to a sense of normalcy and self-esteem, to be a 
distraction from the ongoing focus on cancer19, 33 as well as to provide social networking and 
social support, giving meaning and purpose to their lives.33, 34  
Third, this was one of the first studies to fully examine the relationship between 
attentional fatigue and perceived work ability controlling for known covariates. Our study found 
that attentional fatigue was an important predictor of perceived work ability. The ability to focus 
attention requires continuous mental effort. When activities (such as those associated with 
working) require a prolonged capacity for attention, attentional fatigue may ensue.8 This study is 
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the first to demonstrate a link between attentional fatigue and work ability using the full WAI 
and controlling for known covariates. 
Our findings are supported by qualitative research.  Fitch, Armstrong, and Tsang35 
interviewed a heterogeneous sample of cancer survivors (N = 32), who reported that post-
treatment changes in attention affected work ability. Other qualitative studies have reported 
similar findings. BCS (N = 12) have described attentional fatigue as restricting their work 
activity and work capacity.32 Cancer survivors (N = 29) reported that the inability to concentrate 
disrupted their work ability, negatively affected their productivity, and caused them to feel they 
were “letting [their employers] down.”36  Quantitative studies are limited as the focus has been 
on cognitive function and work ability, not specifically on attentional fatigue. 37-40 
Lastly, our work provides initial support for our adaptation of the Cancer & Work 
model16 in that symptoms such as attentional fatigue may impact work ability in BCS. Working 
is beneficial to BCS; it provides structure and promotes self-esteem, distraction, social 
interaction, and financial stability. The work ability of cancer survivors is a global concern. As 
treatments for cancer continue to emerge and demonstrate effectiveness and as BCS live longer, 
they will make up a larger portion of the global workforce. Employers and health care providers 
need to be aware of potential problems such as attentional fatigue and its impact on work ability. 
In addition, employers need to be educated to identify and assist in addressing the specific needs 
of BCS to improve work ability. 
Implications for Nursing Practice 
Clinicians are in a key position to assess BCS for attentional fatigue and perceived work 
ability. Early identification of those who are experiencing attentional fatigue that impacts their 
work ability is important for both the BCS and employers. Research is needed to inform the 
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development of comprehensive survivorship care plans and pre-emptive interventions to assist 
BCS with strategies to facilitate work ability.   
The National Comprehensive Cancer Network (NCCN)41 identifies strategies to address 
cognitive function in cancer survivors; however, there are very few evidence-based guidelines 
available to practitioners and survivors with tactics to address the disruptive symptom of 
attentional fatigue specifically. First-line intervention recommendations include: 
neuropsychological evaluation, cognitive therapy and physical activity. The use of 
psychostimulants is a second-line intervention. Strategies identified in a summary of qualitative 
studies in cancer survivors have supported these recommendations as well as identified self-
management activities used by BCS to mitigate symptoms. Self-management activities used by 
BCS include: validation of symptoms, self-organizing activities (note keeping, focusing on one 
thing at a time), mind stimulating activities (computer based training, crossword and word search 
puzzles), physical activity (exercise), adequate sleep, stress reduction (massage, meditation, 
yoga, and mindfulness based therapy42 In a recent study, BCS who received a mindfulness-based 
training intervention were assessed at 3 time points (baseline, post-intervention, and 6 months) 
and demonstrated a significant improvement in vitality and cancer-related fatigue.43 More 
research is needed to fully understand the impact of attentional fatigue on work-related outcomes 
in BCS. Future research should include mixed methods and/or longitudinal study designs that 
objectively measure attentional fatigue. In addition, mindfulness-based training interventions can 
be examined to assess its’ impact on attentional fatigue and work ability.  
Limitations 
 
Study findings should be considered in terms of study limitations. The sample size was 
small and consisted of predominately well-educated Caucasian women, limiting its 
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generalizability. The authors recognize there other factors that can affect attentional fatigue, but 
chose for this study to include and examine the most salient factors based on empirical research 
and the sample size.  Lastly, we acknowledge the adapted model used in this study was a small 
portion of the comprehensive Cancer &Work Model, nonetheless the findings provide initial 
evidence of a relationship  between attentional fatigue and empirical support of the model.  
Future studies should include a larger and more diverse samples, be longitudinal in design, and 
should use objective measures of both attention and work-related outcomes (work ability, work 
performance and/or return to work). Studies exploring other prevalent, contributing factors to 
attentional fatigue and/or co-occurring, correlated symptoms or symptom clusters to understand 
fully the impact of symptoms on work ability in BCS are also needed.    
Conclusion 
Our findings indicate that attentional fatigue is a common post-treatment symptom that is 
negatively associated with perceived work ability in BCS. These findings are important and are 
clinically relevant for understanding the impact of cancer and cancer treatment on normal, daily 
activities such as work for BCS. This study suggests the need for individual, comprehensive 
survivorship care plans to effectively address symptoms that impact the quality of life of cancer 
survivors.  
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Figure 1. Conceptual Framework  
Antecedents 
Demographic characteristics 
 Age 
 Education  
 Household income 
Outcome 
 
 
Work ability 
Work Ability Index 
(WAI) 
 
Attentional fatigue 
 Attention Function Index 
(AFI) 
Medical characteristic 
 Time post treatment 
Table 1 Sample Characteristics (N = 68) 
  Mean (SD)       n (%) 
____________________________________________________________________  
Age  52.12 (8.603)  
Race 
African American  4 (5.9)  
 Caucasian   63 (92.6) 
 Missing  1 (1.5) 
Highest Level Education Completed  
 1-11    0 (0) 
 12 (High School)  12 (17.6) 
 13  4 (5.9) 
 14  6 (8.8) 
 16 (College)  23 (33.8) 
17  2 (2.9) 
 18 (Master’s degree)  17 (25)  
 19  1 (1.5) 
 20 (doctorate)  1 (1.5) 
 Missing   2 (2.9) 
 Employment Status       
 Employed Full time   51 (75) 
 Employed Part time  14 (20.6) 
 Missing   3 (4.4) 
 
Type of Employment  
 Professional (law, medicine, teacher, engineer) 29 (42.6) 
 Management/Administration 11 (16.2) 
 Technical (repairman, computer skills) 3 (4.4) 
 Clerical (secretary)  13 (19.1) 
 Service (waiter/waitress, sales) 3 (4.4) 
 Self-employed  1 (1.5) 
 Other  6 (8.8) 
 Missing  2 (2.9) 
Marital Status 
Single  10 (14.7) 
Single/Living with partner 5 (7.4) 
 Married  48 (70.6) 
 Widowed  1 (1.5) 
 Other  3 (4.4) 
 Missing  1 (1.5)  
Income 
 < $15,000  1 (1.5) 
 $15,001 to $30,000  4 (5.9) 
 $30,001 to $50,000  5 (7.4) 
 $50,001 to $75,000  5 (7.4) 
 $75,001 to 100,000  25 (36.8) 
 $100,001 to $150,000  10 (14.7) 
 $150,001 to $200,000  11 (16.2) 
 > $200,000  3 (4.4) 
 Don’t know  1 (1.5) 
 Missing  3 (4.4) 
 
 
 
 
  
Table 2. Attentional Function Index (AFI) and Work Ability Index (WAI) Scores   
AFI n  Mean (SD) Minimum Maximum 
Overall score 68 84 (25) 34 129 
 
Threshold n (%)    
Effective 
functioning >75 
45 (66) 99.2 (14.0) 81 129 
Moderate 
functioning 
50-75  
14 (21) 63.6 (6.0) 52 72 
Lower 
functioning <50 
9 (13) 43.5 (5.0) 34 49 
  
WAI n  Mean (SD) Minimum Maximum 
Overall score 68 38.9 (7.0) 19 49 
 
Threshold n (%)    
Excellent 
(44-49) 
19 (28) 46.6 (1.7) 44 49 
Good  
(37-43) 
31 (46) 40.4 (1.9) 37 43 
Moderate 11 (16) 31.8 (1.9) 29 34 
(28-36) 
Poor 
(7-27) 
7 (10) 23.4 (3.0) 11 27 
 
  
 
 
 
